Sen. Wyden Issues Statement on FDA Decision to Withdraw Emergency Use Authorization on Hydroxychloroquine
June 16, 2020
June 16, 2020
WASHINGTON, June 16 -- Sen. Ron Wyden, D-Oregon, ranking Democratic member of the Senate Finance Committee, issued the following statement after the Food and Drug Administration announced it is withdrawing its emergency use authorization for hydroxychloroquine and chloroquine as a prevention and treatment for COVID-19:
"The FDA withdrew an emergency use authorization that never should have been issued in the first place. By ignoring science and caving to political pressure from . . .
"The FDA withdrew an emergency use authorization that never should have been issued in the first place. By ignoring science and caving to political pressure from . . .